CONSOLIDATED STATEMENTS OF EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common units	Partners' equity	Series B cumulative convertible preferred units Partners' equity
Beginning balance (in shares) at Dec. 31, 2022		209,407
Beginning balance at Dec. 31, 2022			$ 911,451
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of common units (in shares)		(358)
Repurchases of common units			(5,496)
Restricted units granted, net of forfeitures (in shares)		914
Equity–based compensation			5,052
Distributions			(99,600)
Charges to partners' equity for accrued distribution equivalent rights			(733)
Distributions on Series B cumulative convertible preferred units				$ (5,250)
Net income (loss)			134,443
Ending balance (in shares) at Mar. 31, 2023		209,963
Ending balance at Mar. 31, 2023			939,867
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted units granted, net of forfeitures (in shares)		5
Equity–based compensation			2,076
Distributions			(99,734)
Charges to partners' equity for accrued distribution equivalent rights			(471)
Distributions on Series B cumulative convertible preferred units				(5,250)
Net income (loss)			78,392
Ending balance (in shares) at Jun. 30, 2023		209,968
Ending balance at Jun. 30, 2023			914,880
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted units granted, net of forfeitures (in shares)		18
Equity–based compensation			3,530
Distributions			(99,744)
Charges to partners' equity for accrued distribution equivalent rights			(461)
Distributions on Series B cumulative convertible preferred units				(5,250)
Net income (loss)			62,067
Ending balance (in shares) at Sep. 30, 2023		209,986
Ending balance at Sep. 30, 2023			875,022
Beginning balance (in shares) at Dec. 31, 2023		209,991
Beginning balance at Dec. 31, 2023	$ 918,208		918,208
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of common units (in shares)		(287)
Repurchases of common units			(4,381)
Restricted units granted, net of forfeitures (in shares)		952
Equity–based compensation			5,431
Distributions			(99,899)
Charges to partners' equity for accrued distribution equivalent rights			(595)
Distributions on Series B cumulative convertible preferred units				(7,367)
Net income (loss)			63,927
Ending balance (in shares) at Mar. 31, 2024		210,656
Ending balance at Mar. 31, 2024			875,324
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of common units (in shares)		(4)
Repurchases of common units			(68)
Issuance of common units for property acquisitions (in shares)		64
Issuance of common units for property acquisitions			1,039
Restricted units granted, net of forfeitures (in shares)		(34)
Equity–based compensation			1,935
Distributions			(79,014)
Charges to partners' equity for accrued distribution equivalent rights			(185)
Distributions on Series B cumulative convertible preferred units				(7,366)
Net income (loss)			68,322
Ending balance (in shares) at Jun. 30, 2024		210,682
Ending balance at Jun. 30, 2024			859,987
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted units granted, net of forfeitures (in shares)		6
Equity–based compensation			1,726
Distributions			(79,008)
Charges to partners' equity for accrued distribution equivalent rights			(247)
Distributions on Series B cumulative convertible preferred units				$ (7,366)
Net income (loss)			92,731
Ending balance (in shares) at Sep. 30, 2024		210,688
Ending balance at Sep. 30, 2024	$ 867,823		$ 867,823